| Status | Study |
| Withdrawn |
Study Name: A Trial Evaluating Pitolisant (BF2.649) in Alcohol Use Disorder Treatment Condition: Alcohol Abuse, Nervous System Date: 2016-06-07 Interventions: Drug: Pitolisant (BF2.649) Drug: Placebo |
| Recruiting |
Study Name: Optimum Thiamine Intervention (OpTIn) Trial Condition: Wernicke-Korsakoff Syndrome Date: 2014-09-26 Interventions: Drug: Thiamine Hydrochloride Administered Intravenously in 100ml bag of normal saline (0.9%) infused ove |
| Recruiting |
Study Name: Health Mobile Cognitive Stimulation in Alcoholics Condition: Alcohol-Induced Disorders, Nervous System Alcohol Dependence Date: 2013-08-30 Interventions: Other: Mobile health cognitive stimulation |
| Withdrawn |
Study Name: From Uncomplicated Alcoholism to Korsakoff's Syndrome Condition: Alcoholism Alcohol Amnestic Disorder Date: 2011-10-18 Interventions: Behavioral: Neuropsychological testing |
| Terminated |
Study Name: Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD) Condition: Alcohol Withdrawal Delirium Alcohol Withdrawal Associated Autonomic Hyperactivity Date: 2010-05-24 Interventions: Drug: Dexmedetomidine See arm |
| Completed |
Study Name: Somatic Disease Among Alcohol Abusers in an Out-day Patients' Clinic Condition: HEART DISEASE Liver Failure DEPRESSIVE DISORDER Date: 2010-03-04 Interventions: Other: Psychiatric and somatic examinations and ,if clinical indicated, treatment Patients referred to t |
| Completed |
Study Name: Efficacy of Keppra in Acute Alcohol Related Seizure Control--A Pilot Study Condition: Seizure, Alcohol Related Date: 2008-02-20 Interventions: Drug: levetiracetam 2 gram iv load, 500mg bid |
| Completed |
Study Name: Treating Alcohol Withdrawal With Oral Baclofen Condition: Alcohol Withdrawal Delirium Date: 2008-01-09 Interventions: Drug: Baclofen Baclofen 10 mg |
| Completed |
Study Name: Cutaneous Denervation in Alcoholic Neuropathy Condition: Alcohol Abuse Peripheral Neuropathy Date: 2005-09-11 |